Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Total Liabilities: 2010-2025

Historic Total Liabilities for Sunshine Biopharma (SBFM) over the last 12 years, with Sep 2025 value amounting to $7.3 million.

  • Sunshine Biopharma's Total Liabilities rose 45.25% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 45.25%. This contributed to the annual value of $7.1 million for FY2024, which is 14.99% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Total Liabilities is $7.3 million, which was up 16.04% from $6.3 million recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Total Liabilities high stood at $7.6 million for Q4 2022, and its period low was $95,234 during Q1 2022.
  • For the 3-year period, Sunshine Biopharma's Total Liabilities averaged around $6.3 million, with its median value being $6.3 million (2025).
  • In the last 5 years, Sunshine Biopharma's Total Liabilities tumbled by 96.76% in 2022 and then spiked by 7,840.30% in 2023.
  • Sunshine Biopharma's Total Liabilities (Quarterly) stood at $2.0 million in 2021, then soared by 282.49% to $7.6 million in 2022, then dropped by 19.39% to $6.1 million in 2023, then rose by 14.99% to $7.1 million in 2024, then soared by 45.25% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q3 2025, $6.3 million for Q2 2025, and $6.5 million during Q1 2025.